Review
Recombinant Salmonella vectors in vaccine development
Affiliations
- PMID: 7958478
Item in Clipboard
Review
Recombinant Salmonella vectors in vaccine development
Dev Biol Stand.
1994.
Abstract
A diversity of means are available for the attenuation of Salmonella which can be used to immunize animals and humans orally to elicit mucosal, humoral and cellular immune responses. Avirulent Salmonellae can be genetically engineered to express foreign antigens and the recombinant avirulent Salmonellae are capable of stable, high-level expression of the foreign antigen in the orally immunized animal or human host. The resulting vaccines are safe, efficacious, and are easy and economical to use.
Similar articles
-
The use of live attenuated Salmonella for oral vaccination.Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.
-
[Use of Salmonellas as a vector in the designing of recombinant vaccines].Vestn Ross Akad Med Nauk. 1997;(3):43-6. Vestn Ross Akad Med Nauk. 1997. PMID: 9181857 Review. Russian. No abstract available.
-
Salmonellae as oral vaccine carriers.Dev Biol Stand. 1995;84:245-53. Dev Biol Stand. 1995. PMID: 7796961 Review. No abstract available.
-
Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.Parasite Immunol. 1987 Mar;9(2):151-60. doi: 10.1111/j.1365-3024.1987.tb00496.x. Parasite Immunol. 1987. PMID: 3106921 Review.
-
The variation of antigen expression: a natural phenomenon utilised for the construction of live recombinant Salmonella vaccines.Behring Inst Mitt. 1994 Dec;(95):49-56. Behring Inst Mitt. 1994. PMID: 7755509 Review. No abstract available.
Cited by
-
Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment.Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9361-6. doi: 10.1073/pnas.0803801105. Epub 2008 Jul 7. Proc Natl Acad Sci U S A. 2008. PMID: 18607005 Free PMC article.
-
Identification of three highly attenuated Salmonella typhimurium mutants that are more immunogenic and protective in mice than a prototypical aroA mutant.Infect Immun. 1998 Jul;66(7):3378-83. doi: 10.1128/IAI.66.7.3378-3383.1998. Infect Immun. 1998. PMID: 9632608 Free PMC article.
-
The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice.Infect Immun. 1999 Jul;67(7):3674-9. doi: 10.1128/IAI.67.7.3674-3679.1999. Infect Immun. 1999. PMID: 10377159 Free PMC article.
-
Overview of vaccines.Mol Biotechnol. 1997 Oct;8(2):123-34. doi: 10.1007/BF02752256. Mol Biotechnol. 1997. PMID: 9406182 Review.
-
Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.Infect Immun. 2008 Jul;76(7):3241-54. doi: 10.1128/IAI.01623-07. Epub 2008 May 5. Infect Immun. 2008. PMID: 18458067 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical